J Rhinol.  2016 Nov;23(2):97-101. 10.18787/jr.2016.23.2.97.

The Relationship between Obstructive Sleep Apnea and Metabolic Syndrome in Adult

• Park MJ
• Song I
• Joo J
• Kim TM
• Yun HC
• Yoo JH
• Hong SN
• Lee SH

• KMID: 2361322
• DOI: http://doi.org/10.18787/jr.2016.23.2.97

Abstract

BACKGROUND AND OBJECTIVES
The prevalence of obstructive sleep apnea (OSA) and metabolic syndrome (MS) is increasing and those have been recognized as potential risk factors for cardiovascular disease in adults. The aim of this study is to investigate the association between obstructive sleep apnea syndrome and metabolic syndrome.
MATERIALS AND METHODS
We enrolled 127 adults who were evaluated as having OSA. Each subject underwent overnight polysomnography to identify OSA based on the apnea-hypopnea index (AHI); OSA was diagnosed when AHI≥5, and subjects with AHI<5 were classified as the control group. MS was defined according to the Adult Treatment Panel (ATP) III criteria.
RESULTS
Among 127 participants, 105 subjects were diagnosed with OSA. The mean age and smoker percentage showed differences between the OSA and control group. The prevalence of MS was significantly higher in the OSA group compared to the control group. As the severity of OSA increases, the prevalence of MS also increase.
CONCLUSIONS
The MS is significantly related to the OSA in adults. Therefore, we suggest that patient with OSA should be screened to identify the presence of MS.

Keyword

Metabolic syndrome; Obstructive sleep apnea; Prevalence

MeSH Terms

Adult*
Cardiovascular Diseases
Humans
Polysomnography
Prevalence
Risk Factors
Sleep Apnea, Obstructive*

Reference

References

1). Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993; 328(17):1230–5.

2). Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypop-noea with or without treatment with continuous positive airway pressure: an observational study. Lancet. 2005; 365(9464):1046–53.

3). Coughlin SR, Mawdsley L, Mugarza JA, Wilding JP, Calverley PM. Cardiovascular and metabolic effects of CPAP in obese males with OSA. Eur Respir J. 2007; 29(4):720–7.

4). Faccenda JF, Mackay TW, Boon NA, Douglas NJ. Randomized pla-cebo-controlled trial of continuous positive airway pressure on blood pressure in the sleep apnea-hypopnea syndrome. Am J Respir Crit Care Med. 2001; 163(2):344–8.

5). Chung YS. Pathogenesis of Obstructive Sleep Apnea. J Rhinol. 2009; 16(2):87–90.

6). Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988–1994. Arch Intern Med. 2003; 163(4):427–36.

7). Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005; 365(9468):1415–28.

8). Lim S, Shin H, Song JH, Kwak SH, Kang SM, Won Yoon J, et al. Increasing prevalence of metabolic syndrome in Korea: the Korean National Health and Nutrition Examination Survey for 1998–2007. Diabetes Care. 2011; 34(6):1323–8.

9). Novo S, Peritore A, Guarneri FP, Corrado E, Macaione F, Evola S, et al. Metabolic syndrome (MetS) predicts cardio and cerebrovascular events in a twenty years follow-up. A prospective study. Atherosclerosis. 2012; 223(2):468–72.

10). Spiegel K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet. 1999; 354(9188):1435–9.

11). Mo JH. Obstructive Sleep Apnea and Systemic Diseases. J Rhinol. 2013; 20(1):8–13.

12). Iber C A-IS. Chesson AL, Quan SF. The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology, and Technical Specifications. American Academy of Sleep Medicine. 2007.

13). Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001; 285(19):2486–97.

14). Bonsignore MR, Esquinas C, Barcelo A, Sanchez-de-la-Torre M, Pa-terno A, Duran-Cantolla J, et al. Metabolic syndrome, insulin resistance and sleepiness in real-life obstructive sleep apnoea. Eur Respir J. 2012; 39(5):1136–43.

16). Poirier P, Despres JP. Waist circumference, visceral obesity, and cardiovascular risk. J Cardiopulm Rehabil. 2003; 23(3):161–9.

17). Franklin SS. The importance of diastolic blood pressure in predicting cardiovascular risk. J Am Soc Hypertens. 2007; 1(1):82–93.

18). Gruber A, Horwood F, Sithole J, Ali NJ, Idris I. Obstructive sleep apnoea is independently associated with the metabolic syndrome but not insulin resistance state. Cardiovasc Diabetol. 2006; 5:22.

19). Tasali E, Leproult R, Ehrmann DA, Van Cauter E. Slow-wave sleep and the risk of type 2 diabetes in humans. Proc Natl Acad Sci U S A. 2008; 105(3):1044–9.

20). Spiegel K, Tasali E, Penev P, Van Cauter E. Brief communication: Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann Intern Med. 2004; 141(11):846–50.

21). Pejovic S, Vgontzas AN, Basta M, Tsaoussoglou M, Zoumakis E, Vgontzas A, et al. Leptin and hunger levels in young healthy adults after one night of sleep loss. J Sleep Res. 2010; 19(4):552–8.

22). Lin QC, Zhang XB, Chen GP, Huang DY, Din HB, Tang AZ. Obstructive sleep apnea syndrome is associated with some components of metabolic syndrome in nonobese adults. Sleep Breath. 2012; 16(2):571–8.

23). Lavie L. Oxidative stress–a unifying paradigm in obstructive sleep apnea and comorbidities. Prog Cardiovasc Dis. 2009; 51(4):303–12.

24). He Q, Yang QC, Zhou Q, Zhu H, Niu WY, Feng J, et al. Effects of varying degrees of intermittent hypoxia on proinflammatory cytokines and adipokines in rats and 3T3-L1 adipocytes. PLoS One. 2014; 9(1):e86326.